Expert Roundtable: Emerging Questions in ErbB2-Positive Breast Cancer; February 22, 2007

An expert roundtable composed of leaders in the field of ErbB2-positive breast cancer was convened on February 22, 2007, to discuss emerging issues regarding the biology of HER2-positive disease, potential mechanisms of resistance to current treatments, and novel treatment options for patients with progressive disease.